Arizona State, Mayo Clinic Researchers Identify Potential New Biomarkers for Diagnosing Crohn’s

Arizona State, Mayo Clinic Researchers Identify Potential New Biomarkers for Diagnosing Crohn’s
Researchers have identified novel biomarkers for diagnosing Crohn’s disease in a collaborative study between Arizona State University’s Biodesign Institute and the Mayo Clinic. They also built a novel blood test that distinguishes patients from healthy individuals. Their study, “Identification of antibody against SNRPB, small nuclear ribonucleoprotein-associated proteins B and B’, as an autoantibody marker in Crohn’s disease

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *